| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $169.7M | +7.6% |
| Cost of Revenue | $86.8M | -0.5% |
| Gross Profit | $82.9M | +17.6% |
| R&D Expense | $60.9M | -9.5% |
| SG&A Expense | $200.8M | -7.6% |
| Operating Income | -$273.9M | -27.8% |
| Pre-tax Income | -$256.5M | -29.0% |
| Income Tax | $107K | -41.8% |
| Net Income | -$256.6M | -28.9% |
| EPS (Basic) | -$0.80 | -21.2% |
| EPS (Diluted) | -$0.80 | -21.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $57.2M | -31.0% |
| Accounts Receivable | $13.2M | -22.1% |
| Inventory | $5.6M | -38.8% |
| Current Assets | $370.4M | -12.4% |
| Total Assets | $543.7M | -5.8% |
| Current Liabilities | $143.7M | +224.9% |
| Total Liabilities | $146.5M | +206.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.3M | +63.7% |
| Capital Expenditures | $246K | +77.0% |
| Investing Cash Flow | $89.8M | +359.4% |
| Financing Cash Flow | $2.6M | -46.1% |
| Free Cash Flow | -$21.6M | +63.4% |
| Stockholders' Equity |
| $397.1M |
| -25.0% |